Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
City of Hope Comprehensive Cancer Center, Duarte, California University of California San Francisco Medical Center, San Francisco, California University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora, Colorado Dana-Farber Cancer Institute, Boston, Massachusetts